Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Kazado Daniel Create: Alert

All | News | Filings
Date FiledTypeDescription
01/27/2017 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 500,000 options @ $0.2, valued at $100k
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/20/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/04/2016 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 666,667 shares @ $0.45, valued at $300k
06/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/02/2016 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 40,000 options @ $0.53, valued at $21.2k
12/08/2015 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 150,000 shares @ $0.7807, valued at $117.1k
09/16/2015 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 50,000 shares @ $1.4696, valued at $73.5k
07/31/2015 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Converted 14,656 shares @ $1.51, valued at $22.1k
Converted 20 convertible preferred @ $1.51, valued at $30.2
01/12/2015 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Granted 50,000 options @ $2.2, valued at $110k
12/03/2014 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 8,000 shares @ $2.5, valued at $20k
Bought 2,000 warrants @ $3.75, valued at $7.5k
06/25/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
03/12/2014 4 Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns: Bought 40 convertible preferred @ $0
Bought 5,883 warrants @ $0
Bought 5,883 options to buy @ $0
10/16/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy